Triathlon Medical Venture Partners logo

Triathlon Medical Venture Partners

North America, Ohio, United States, Cincinnati

Description

Triathlon Medical Venture Partners, also known as Triathlon Medical Ventures, is a Midwest-based venture capital firm with a dedicated focus on early-stage life sciences companies. Headquartered in Cincinnati, Ohio, the firm has established itself as a significant investor in the biotechnology, medical device, diagnostics, and pharmaceutical sectors. Their investment philosophy centers on identifying companies with robust intellectual property, addressing clear unmet clinical needs, and led by experienced management teams.

The firm typically seeks to partner with companies that are past the initial concept phase and are poised for significant growth. They often take an active role in their portfolio companies, leveraging their deep industry expertise and network to provide strategic guidance and support. Triathlon Medical Venture Partners emphasizes a collaborative approach, working closely with founders to navigate the complex landscape of product development, regulatory approvals, and market commercialization.

Triathlon Medical Ventures has a history of successful fundraises, demonstrating sustained commitment to the life sciences industry. Their first fund, Triathlon Medical Ventures Fund I, L.P., was established in 2001 with capital commitments totaling $50 million. Building on this success, they launched Triathlon Medical Ventures Fund II, L.P. in 2007, which secured $100 million in capital commitments. The firm's typical initial investment ranges from $2 million to $5 million, with additional capital reserved for follow-on rounds to support the long-term growth and success of their portfolio companies.

Investor Profile

Triathlon Medical Venture Partners has backed more than 35 startups, with 0 new investments in the last 12 months alone. The firm has led 8 rounds, about 23% of its total and boasts 10 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series C, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States, United Kingdom, Israel.
  • Strong thematic focus on Health Care, Biotechnology, Medical.
  • Typical check size: $2M – $5M.

Stage Focus

  • Series B (26%)
  • Series C (20%)
  • Series Unknown (20%)
  • Series A (17%)
  • Series E (6%)
  • Series D (6%)
  • Series H (3%)
  • Series G (3%)

Country Focus

  • United States (91%)
  • United Kingdom (6%)
  • Israel (3%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Therapeutics
  • Pharmaceutical
  • Manufacturing
  • Life Science
  • Health Diagnostics
  • Product Design
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Triathlon Medical Venture Partners frequently co-invest with?

New Science Ventures
North America, Connecticut, United States, Greenwich
Co-Investments: 5
Blue Chip Venture Company
North America, Ohio, United States, Cincinnati
Co-Investments: 5
Athenian Venture Partners
North America, Florida, United States, Fort Lauderdale
Co-Investments: 5
Orchard Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 4
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 6
Domain Associates
North America, California, United States, San Diego
Co-Investments: 4
Satter Investment Management
North America, Illinois, United States, Chicago
Co-Investments: 4
Kearny Venture Partners
North America, California, United States, San Francisco
Co-Investments: 6
Venture Investors
North America, Wisconsin, United States, Madison
Co-Investments: 8
Oxford Bioscience Partners
North America, Massachusetts, United States, Boston
Co-Investments: 6

What are some of recent deals done by Triathlon Medical Venture Partners?

Aerpio Pharmaceuticals

Cincinnati, Ohio, United States

Aerpio Pharmaceuticals is a biotechnology company that develops small molecules and monoclonal antibodies for vascular diseases treatment.

BiotechnologyHealth CareTherapeutics
Series UnknownMar 16, 2017
Amount Raised: $40,000,000
CoLucid Pharmaceuticals

Durham, North Carolina, United States

CoLucid Pharmaceuticals is a biotechnology company focusing on therapies for central nervous system disorders.

BiotechnologyMedical DevicePharmaceutical
Series CJan 13, 2015
Amount Raised: $37,100,000
Aerpio Pharmaceuticals

Cincinnati, Ohio, United States

Aerpio Pharmaceuticals is a biotechnology company that develops small molecules and monoclonal antibodies for vascular diseases treatment.

BiotechnologyHealth CareTherapeutics
Series CApr 23, 2014
Amount Raised: $22,000,000
Alluxa

Santa Rosa, California, United States

Alluxa is a manufacturer of optical filters and thin-film coatings in Santa Rosa, California.

Electrical DistributionLaserManufacturingNanotechnologyTelecommunications
Series UnknownApr 18, 2014
Amount Raised: $7,000,000
Aerpio Pharmaceuticals

Cincinnati, Ohio, United States

Aerpio Pharmaceuticals is a biotechnology company that develops small molecules and monoclonal antibodies for vascular diseases treatment.

BiotechnologyHealth CareTherapeutics
Series ANov 6, 2013
Amount Raised: $36,000,000
Akebia Therapeutics

Cambridge, Massachusetts, United States

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

BiotechnologyHealth CareTherapeutics
Series CJun 4, 2013
Amount Raised: $41,000,000
Tolera Therapeutics

Kalamazoo, Michigan, United States

Tolera Therapeutics is a spin-off of the Cleveland Clinic focused on bringing specific and safer therapies to treat various diseases.

BiotechnologyMedicalTherapeutics
Series BOct 16, 2012
Amount Raised: $5,500,000
Juventas Therapeutics

Cleveland, Ohio, United States

Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.

BiotechnologyHealth CareLife ScienceMedicalMedical DeviceTherapeutics
Series BJul 16, 2012
Amount Raised: $22,200,000
Mitralign

Tewksbury, Massachusetts, United States

Mitralign is focused on developing a catheter-based technology for the percutaneous treatments of functional mitral regurgitation.

Health CareMedicalMedical Device
Series DMay 16, 2012
Amount Raised: $35,000,000
CoLucid Pharmaceuticals

Durham, North Carolina, United States

CoLucid Pharmaceuticals is a biotechnology company focusing on therapies for central nervous system disorders.

BiotechnologyMedical DevicePharmaceutical
Series UnknownAug 30, 2011
Amount Raised: $7,500,000